About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 22 record(s)
Req # A-2021-09955
Copy of the French version of the February 9, 2021 communication plan titled "Modern and Proactive Communications Strategy".Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-11663
A copy of the release package that was disclosed in response to access to information request file number A-2021-007891.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-11666
A copy of the PMPRB's 6-page Communication Plan, "Modern and Proactive Communications Strategy", dated February 9, 2021 as previously disclosed in a release package in response to an access to information request.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-11668
Copies of the email chain between Michell Levine, Isabel Jaen Raasch, Tanya Potashnik, Douglas Clark, Guillaume Couillard, Riaz Awadia and Elena Lungu having the subject line "Call with IMC this morning", dated December 5, 2019.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2020-03991
Copies of all records, analysis, correspondence, discussions, briefings, memos and decisions, about the development of the PMPRB regulations involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, and EX-all…Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2020-03992
Copies of all analysis, correspondence, discussions, briefings and memos about the evaluation of stakeholder submissions for the PMPRB regulations (including submissions relating to the 2016 PMPRB guidelines modernization, the 2017 consultations on…Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2021-05507
Copies of all communications to/from Douglas Clark regarding the timelines of CADTH and pCPA's drug review process from June 1, 2019 to March 3, 2021.Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2021-05508
Copies of all communications between Douglas Clark (PMPRB executive) and officials in Health Canada's Health Products and Food Branch from January 1, 2020 to March 3, 2021.Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2021-05509
Copies of all communications between Douglas Clark and officials in Health Canada's Health Products and Food Branch regarding the drug Trikafta from Vertex Pharmaceuticals.Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2021-05511
Copies of all communications between Douglas Clark and officials in CADTH and pCPA regarding the drug Trikafta.Organization: Patented Medicine Prices Review Board Canada
April 2021